Samyang Holdings decides to merge with Samyang BioPharm
Samyang Holdings decides to merge with Samyang BioPharm
  • 이지선 기자
  • 승인 2021.01.27 14:56
  • 최종수정 2021.01.27 13:56
  • 댓글 0
이 기사를 공유합니다

 

[Infostock Daily=Reporter Lee Ji-sun] Samyang Holdings announced on the 27th that it will absorb and merge Samyang BioPharm, a subsidiary specializing in the pharmaceutical bio business.

Samyang Holdings plans to complete the merger on April 1 through related procedures.

Through this merger, Samyang Holdings plans to promote mid- to long-term corporate value by leading the pharmaceutical bio business.

Samyang Biopharm expects that it will be able to secure funds for planned mid- to long-term investments in the future, including the development of new drugs and new global businesses, and increase its global credibility to accelerate its tap into the global market.

Reporter Lee Ji-sun stockmk2020@gmail.com
 


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.